# A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence

> **NCT04844840** · PHASE2 · COMPLETED · sponsor: **Sirnaomics** · enrollment: 29 (actual)

## Conditions studied

- Keloid

## Interventions

- **DRUG:** STP705
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04844840
- **Lead sponsor:** Sirnaomics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-29
- **Primary completion:** 2023-05-17
- **Final completion:** 2023-05-17
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2024-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04844840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04844840, "A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04844840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*